Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium for Supported Ventilation in ARDS
NCT02064140Completed
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of rocuronium in acute respiratory distress syndrome (ARDS), sponsored by Radboud University Medical Center. Primary endpoint: Feasibility of titrating tidal volume < 6 ml/kg at 5 minutes. Started Feb 2014; status: completed.
02
Drugs
rocuronium
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT02064140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02064140.